These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 93129)

  • 21. Measurement of Gross cell-surface antigen and p30 level in murine retrovirus-infected cell lines.
    Gerlier D; Gisselbrecht S; Guillemain B; Doré JF
    Br J Cancer; 1981 May; 43(5):659-68. PubMed ID: 7248150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. II. Altered gp70 display and production of noninfectious virus particles by an insusceptible variant tumor.
    Green WR; Brown MA
    Eur J Immunol; 1983 Nov; 13(11):871-7. PubMed ID: 6196207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type-C virus structural antigens on the surface of the infected cell as determined by a humoral cytotoxicity assay.
    Kende M; Sass B; Hino S; Donahoe RM; Kelloff GJ
    Int J Cancer; 1978 Feb; 21(2):194-203. PubMed ID: 75192
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunoprevention of naturally occurring endogenous murine type-C RNA viruses.
    Kende M; Stephenson JR; Kelloff GJ; Al-Ghazzouli IK; Dinowitz M
    Nature; 1978 Jun; 273(5661):383-5. PubMed ID: 207991
    [No Abstract]   [Full Text] [Related]  

  • 25. Group-specific antigen of murine leukemia viruses in mice of low-leukemic strains.
    Abelev GI; Elgort DA
    Int J Cancer; 1970 Sep; 6(2):145-52. PubMed ID: 4320294
    [No Abstract]   [Full Text] [Related]  

  • 26. Properties of mouse leukemia viruses. II. Isolation of viral components.
    Schäfer W; Lange J; Fischinger PJ; Frank H; Bolognesi DP; Pister L
    Virology; 1972 Jan; 47(1):210-28. PubMed ID: 4110127
    [No Abstract]   [Full Text] [Related]  

  • 27. Amplified expression of murine leukemia virus (MuLV)-coded antigens on thymocytes and leukemia cells of AKR mice after infection by dualtropic (MCF) MuLV.
    O'Donnell PV; Nowinski RC; Stockert E
    Virology; 1982 Jun; 119(2):450-64. PubMed ID: 6177096
    [No Abstract]   [Full Text] [Related]  

  • 28. Biological expression of antigenic determinants of murine leukemia virus proteins gp69-71 and p30.
    Ikeda H; Pincus T; Yoshiki T; Strand M; August JT; Boyse EA; Mellors RC
    J Virol; 1974 Nov; 14(5):1274-80. PubMed ID: 4139291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Group-specific cytolytic antibody directed against the major glycoprotein (gp70) of murine leukemia viruses in serum of mice with dormant FLV infections.
    Callahan RM; Marx PA; Wheelock EF
    Virology; 1979 Aug; 97(1):55-67. PubMed ID: 224581
    [No Abstract]   [Full Text] [Related]  

  • 30. Properties of mouse leukemia viruses. I. Characterization of various antisera and serological identification of viral components.
    Schäfer W; Fischinger PJ; Lange J; Pister L
    Virology; 1972 Jan; 47(1):197-209. PubMed ID: 4333567
    [No Abstract]   [Full Text] [Related]  

  • 31. Lysis of retroviruses with monoclonal antibodies against viral envelope proteins.
    Oroszlan S; Nowinski RC
    Virology; 1980 Feb; 101(1):296-9. PubMed ID: 6243827
    [No Abstract]   [Full Text] [Related]  

  • 32. Identification of the Gross cell surface antigen associated with murine leukemia virus-infected cells.
    Ledbetter J; Nowinski RC
    J Virol; 1977 Aug; 23(2):315-22. PubMed ID: 69726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the susceptibility of C57BL-6 mice to Rauscher virus. 3. Kinetics of humoral antibody response to cell-surface antigens in neonatally inoculated mice.
    Ishimoto A; Ito Y
    J Natl Cancer Inst; 1973 Aug; 51(2):553-64. PubMed ID: 4765372
    [No Abstract]   [Full Text] [Related]  

  • 34. Antiviral antibodies inhibit the lysis of tumour cells by anti-H--2 sera.
    Henning R; Schrader JW; Edelman GM
    Nature; 1976 Oct; 263(5579):689-91. PubMed ID: 185524
    [No Abstract]   [Full Text] [Related]  

  • 35. Serologically defined antigens on the surface of somatic hybrid cells.
    Rubio N
    Int Arch Allergy Appl Immunol; 1982; 67(2):123-6. PubMed ID: 7056591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-leukemogenic variants of Rauscher leukemia virus obtained in long-term cultures at supra-optimal temperature.
    Barski G; Barbieri D; Youn JK; Hue G
    Int J Cancer; 1973 Jul; 12(1):55-65. PubMed ID: 4597863
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of chemical modification and fragmentation on antigenic determinants of internal protein p30 and surface glycoprotein gp70 of type C retroviruses.
    Versteegen RJ; Oroszlan S
    J Virol; 1980 Mar; 33(3):983-92. PubMed ID: 6154154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AKR-MuLV-associated cell surface antigens.
    Ihle JN; Longstreth JD; Pazmiño NH; McLellan WL; Hanna MG
    Med Microbiol Immunol; 1977; 164(1-3):179-95. PubMed ID: 202850
    [No Abstract]   [Full Text] [Related]  

  • 39. H-2-restricted cytolytic T lymphocytes specific for a subclass of AKR endogenous leukemia virus-induced tumors: correlation of tumor cell susceptibility with expression of the gross cell surface antigen.
    Green WR
    J Immunol; 1980 Dec; 125(6):2584-90. PubMed ID: 6159413
    [No Abstract]   [Full Text] [Related]  

  • 40. Neutralization kinetics of friend and Rauscher leukemia viruses studied with the spleen focus assay method.
    Steeves RA; Axelrad AA
    Int J Cancer; 1967 May; 2(3):235-44. PubMed ID: 6041991
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.